The increased expression of ECM genes/proteins by ALDH1A1 positive cells gives evidence that cancer cells exposed to paclitaxel and topotecan are able to develop a new mechanism of drug resistance combining the models known so far as separate ones (CSCs and ECM). The gene discussed is ALDH1A1; the disease is cancer.